Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+105.1%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
+105.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025147.53%
20246.66%
202321.72%
202217.10%
2021-96.71%
2020-111.74%
2019-189.51%
2018-251.32%
20170.00%